831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1827577896272658432 |
|---|---|
| author | Yin Wang Wei Shi Di Zhao |
| author_facet | Yin Wang Wei Shi Di Zhao |
| author_sort | Yin Wang |
| collection | DOAJ |
| first_indexed | 2024-03-08T21:34:27Z |
| format | Article |
| id | doaj.art-9c31c4e081d14bb6b997ebd9306e8577 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-08T21:34:27Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-9c31c4e081d14bb6b997ebd9306e85772023-12-21T01:10:13ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0831831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficienciesYin Wang0Wei Shi1Di Zhao2The University of Texas MD Anderson Cancer Center, Houston, TX, USAThe University of Texas MD Anderson Cancer Center, Houston, TX, USAThe University of Texas MD Anderson Cancer Center, Houston, TX, USA |
| spellingShingle | Yin Wang Wei Shi Di Zhao 831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies Journal for ImmunoTherapy of Cancer |
| title | 831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies |
| title_full | 831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies |
| title_fullStr | 831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies |
| title_full_unstemmed | 831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies |
| title_short | 831 Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies |
| title_sort | 831 immune checkpoint b7 h3 is a therapeutic vulnerability in prostate cancer harboring pten and tp53 deficiencies |
| work_keys_str_mv | AT yinwang 831immunecheckpointb7h3isatherapeuticvulnerabilityinprostatecancerharboringptenandtp53deficiencies AT weishi 831immunecheckpointb7h3isatherapeuticvulnerabilityinprostatecancerharboringptenandtp53deficiencies AT dizhao 831immunecheckpointb7h3isatherapeuticvulnerabilityinprostatecancerharboringptenandtp53deficiencies |